Assorted News from the Last Week:
Making symptoms visible: The impact of real-time PROM integration in pediatric oncology.
Little Heroes: EU Parliament pays tribute to child cancer victims with Brussels art exhibition.
By combining second-generation RRM2 and CHK1 inhibitors, neuroblastoma researchers were able to overwhelm the cancer cells’ ability to repair their own DNA, leading to tumor regression in preclinical models.
Advocacy groups are sounding the alarm as Federal funding for the PBTC is slated to end in March 2026. Since 1999, this network has led early-phase trials for the deadliest pediatric brain cancers.
Describing deaths over a decade: The final week of life among hospitalized children with cancer
Upcoming Webinars, Online Opportunities, and Meetings:
Following the cancellation of the 2025 Childhood Cancer Data Initiative (CCDI) Symposium originally scheduled for last fall, NCI will inaugurate the CCDI Virtual Symposium Series in the coming weeks. Sessions will occur across multiple days in March and April. Click Here to Learn More and Register.
Elevate Childhood Cancer, in partnership with the Kidney Cancer Association, will host the FIRST-ever Wilms Tumor Virtual Forum: Connecting Families and Experts on April 30, 2026. Click here for more information and to register.
11th International Nursing Conference on Child and Adolescent Cancer Survivorship in Philadelphia on April 30 and May 1. Click here for more information and to register.
Richi Foundation invites the public to the Carnival of Colors to celebrate, foster community, and enjoy being together from 11:00 am to 5:00 pm ET on May 2. Click here for more information and to register.
National Brain Tumor Society and volunteer advocates from across the country will come together in Washington, D.C., for Head to the Hill on May 3-5, 2026. Register today.
Started in 2017, the annual MIB Agents FACTOR conference brings together the leading researchers, clinicians, and surgeons, along with patient families and OsteoWarriors (survivors, patients, and siblings of OsteoWarriors and OsteoAngels) to Make It Better for those battling this disease. This year the meeting will be in Columbus, Ohio June 25-27. Click here for information and to register.
Take Action:
Do you know researchers work in drug discovery? Connect them to C-Further.
C-Further is an international paediatric cancer therapeutics consortium providing funding, expertise, and access to cutting-edge facilities to help researchers advance their discovery into a therapy that makes a real difference for children and young people with cancer.
The next expression of interest deadline is 13 March 2026.
We’d be grateful if you could share this with researchers in your network who might be interested in applying: https://bit.ly/3ZOROH9
The American Association for Cancer Research (AACR) is pleased to invite patient advocacy organizations working within the cancer community to exhibit in the Advocacy Partners Pavilion at the AACR Annual Meeting 2026 in San Diego, CA (April 17-22, 2026). Due to overwhelming interest from the advocacy community, AACR has opened additional booths, but availability remains limited. There is no fee to exhibit in the Advocacy Partners Pavilion. Accepted exhibitors will receive two (2) complimentary all-access passes to the conference, on-demand recordings, use of the Advocate Lounge, and five (5) complimentary exhibitor badges. Exhibitors are accepted on a first-come, first-served basis and only a few spaces remain.
The ASCO-Sponsored Patient Advocacy Booth provides an opportunity for not-for-profit patient advocacy organizations to promote their programs, services, and resources to the professional oncology community. The booth provides a venue where participants can display materials and where meeting attendees and patient advocates can meet, interact, and exchange information. Learn more.
The Conquer Cancer® Patient Advocate Award Program provides a limited number of awards for patient advocates to attend the ASCO Annual Meeting to learn of important advances in their areas of interest. Awards help cover travel, hotel, and registration expenses and are based primarily on financial need, advocacy experience, and current advocacy activities and involvement. The application period opens Monday, March 9 at 10:00 AM (ET) and closes Monday, March 16 at 5:00 PM (ET).
SUBSCRIBE
Sign up to receive a copy of CAC2’s free childhood cancer news digest in your inbox each week.
